JOURNAL OF CLINICAL SURGERY ›› 2022, Vol. 30 ›› Issue (12): 1172-1175.doi: 10.3969/j.issn.1005-6483.2022.12.021

Previous Articles     Next Articles

Prediction of postoperative survival of triple-negative breast cancer combined with expression of HIF-1α and c-myc

  

  1. Department of Cardiovascular Surgery, Zhongnan Hospital of Wuhan University,Wuhan 430071,China
  • Received:2022-05-08 Accepted:2022-05-08 Online:2022-12-20 Published:2023-01-20

Abstract: Objective To determine the expression of HIF-1α and c-myc in triple-negative breast cancer and establish a predictive model for postoperative survival.Methods Tissue microarray including clinical and follow-up data of 161 triple negative breast cancer patients was selected in this study.Immunohistochemistry was performed to detected the expression of HIF-1α and c-myc protein in breast cancer tissues.We used cox regression analysis to explore the correlation between HIF-1α/c-myc expression and clinical pathological parameters as well as prognosis.ROC curve was generated for cox multivariate analysis.A nomogram was generated based on the cox multivariate analysis.Results The positive expression rates of HIF-1α and c-myc protein in breast cancer tissues were 45.3%(73/161) and 59.0%(95/161),respectively.Cox univariate and multivariate analysis showed that HIF-1α and c-myc protein expression,histological grade,lymph node status,and tumor TNM stage were the independent risk factors for postoperative survival in triple-negative breast cancer patients.The AUC of prediction model was 0.820(0.796-0.854).The nomogram could predict the probability of 3 years disease free survival according to each patient's condition.Conclusion High expression of HIF-1α and c-myc,as well as histological grade Ⅲ,positive lymph node,stage Ⅲ tumors suggest that patients with triple-negative breast cancer have a poor prognosis.The prediction model can be used to predict postoperative survival.

Key words: triple-negative breast cancer, HIF-1α, c-myc, nomogram, prognosis

[1] XUE Zhiyou, NI Zhihai, ZHANG Yi. Relationship between the expression of retinoid acid receptor related orphan receptorα and microtubuleassociated protein light chain 3 in gastric cancer and long-term prognosi [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(9): 839-843.
[2] JI Jintao, KANG Bo, SUYansheng. Correlation analysis of PSMA with Gleason score and its value in early diagnosis and prognosis of prostate cancer [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(9): 885-888.
[3] YUAN Ye, LIU Tao, LIU Hua. Relationship between the expression levels of microRNA-138 and microRNA-145 and Th1/Th2 drift and prognosis in esophageal squamous cell carcinoma [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(8): 744-748.
[4] LUO Yaobing, YANG Wujun, WANG Xingping, et al. Effect of stepped decompression under intracranial pressure monitoring on inflammatory response,metabolic status and prognosis of patients with emergency craniocerebral trauma [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(7): 640-643.
[5] LIU Guolu, LI Qiang, LI Qian, et al. Relationship between circulating miR-485-5p and pathological parameters in patients with prostate cancer and its prognostic value [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(7): 673-676.
[6] YUAN Zhao, ZHENG Ang. Analysis of clinical efficacy hemodynamic indexes and prognosis of laparoscopic splenectomy and EVLS therapy in the treatment ofportal hypertension patients [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(7): 691-693.
[7] LI Zongfu, CHEN Tieliang, DING Mei, et al. Analysis of the effect of rapid rehabilitation surgery on the nutritional status of patients undergoing laparoscopic-assisted pyloric sparing gastrectomy for early gastric cancer [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(5): 433-436.
[8] RUAN Tian, LI Changsheng, YANG Zetian, et al. The effect of visceral pleural invasion on the survival of postoperative patients with stage ⅢA/N2 non-small cell lung cancer:SEER database analysis [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(5): 448-452.
[9] YE Bin, XIANG Qiu, JIN Wenjie. Expression of forkhead box Q1 and CyclinD1 in non-small cell lung cancer and their relationship with clinicopathological features and prognosis [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(5): 453-458.
[10] BIAN Chunan, TIAN Xiaoqi, LIN Chaoyu, et al. Differentiated expression and clinical significance of crystallin-alpha B in lung squamous cell carcinoma [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(5): 486-489.
[11] YANG Heng, ZHANG Jun, GUO Qiang, et al. The potential value of HLA-DPB1 in lung adenocarcinoma was analyzed based on multi-database [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(4): 339-344.
[12] JIN Yi , WANG Xinyi, DU Runsen, et al. Decreased expression of hsa-mir-337 predicts poor prognosis in patients with breast cancer [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(4): 345-348.
[13] WANG Pengyuan, SHANG Yichao, ZHENG Duo, et al. Prognostic analysis of pelvis and ureteral carcinoma [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(4): 368-371.
[14] LU Kaijin, SHEN Jiangfeng, JIA Weiguang. Effect of thoracoscopic modified recurrent laryngeal nerve lymph node dissection for esophageal cancer and its effect on patient prognosis [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(3): 257-260.
[15] SHEN Jian, LI Minzhe, DU Yanfu. Effect of central obesity on clinical efficacy of laparoscopic D2 radical gastrectomy for distal gastric cancer [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(3): 261-265.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 741 .
[2] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 756 .
[3] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 772 .
[4] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 792 .
[5] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 785 .
[6] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 808 .
[7] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 809 .
[8] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 812 .
[9] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 821 .
[10] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 824 .